Cargando…
Opportunities for Synthetic Biology in Antibiotics: Expanding Glycopeptide Chemical Diversity
[Image: see text] Synthetic biology offers a new path for the exploitation and improvement of natural products to address the growing crisis in antibiotic resistance. All antibiotics in clinical use are facing eventual obsolesce as a result of the evolution and dissemination of resistance mechanisms...
Autores principales: | Thaker, Maulik N., Wright, Gerard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384835/ https://www.ncbi.nlm.nih.gov/pubmed/23654249 http://dx.doi.org/10.1021/sb300092n |
Ejemplares similares
-
Harnessing synthetic biology to expand chemical diversity of antibiotics
por: Enam, Fatima
Publicado: (2021) -
GPAHex-A synthetic biology platform for Type IV–V glycopeptide antibiotic production and discovery
por: Xu, Min, et al.
Publicado: (2020) -
Phylogeny-Informed Synthetic Biology Reveals Unprecedented
Structural Novelty in Type V Glycopeptide Antibiotics
por: Xu, Min, et al.
Publicado: (2022) -
Synthetic Biology
Facilitates Semisynthetic Development
of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus
por: Koteva, Kalinka, et al.
Publicado: (2023) -
Synthetic glycopeptides and glycoproteins with applications in biological research
por: Westerlind, Ulrika
Publicado: (2012)